Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma-Reference-Cited by-同舟云学术

Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma

Published:2018-03 Issue: Volume:91 Page:136-144
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Dercle Laurent,Ammari Samy,Seban Romain-David,Schwartz Lawrence H.,Houot Roch,Labaied Nizar,Mokrane Fatima-Zohra,Lazarovici Julien,Danu Alina,Marabelle Aurélien,Ribrag Vincent,Michot Jean-Marie

Funder

Philanthropia Foundation, Geneva, Switzerland

ARC foundation, Villejuif, France

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference17 articles.

1. Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure;Armand;J Clin Oncol,2016

2. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma;Ansell;N Engl J Med,2015

3. PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome;Roemer;J Clin Oncol,2016

4. 18F-FDG PET and CT scans detect new imaging patterns of response and progression in patients with Hodgkin lymphoma treated by anti–programmed death 1 immune checkpoint inhibitor;Dercle;J Nucl Med,2018

5. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy;Cheson;Blood,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients;Scientific Reports;2024-06-01

2. Healthy Tissue Metabolism Assessed by [18F]FDG PET/CT as a Marker of Prognosis and Adverse Events in Advanced Hodgkin Lymphoma Patients;2024-02-21

3. Nanotechnology Potent Photothermal and Photodynamic Immunotherapies of Cancer;Journal of Medical and Biological Engineering;2023-11-10

4. Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas;Cancers;2023-09-21

5. PET/CT in Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05